How profitable is Balchem Corporation (BCPC)?

In FY 2025 (10-K), BCPC converted $1.0B of revenue into a 35.7% gross margin, 20.2% operating margin, and $216.6M in free cash flow (20.9% FCF margin).

Stock Ratings / Materials / BCPC / financials

CE (44) MEOH (65) SXT (55) HXL (51) ⌘ Pro Terminal →

Balchem Corporation (BCPC) Revenue-to-Profit Sankey Flow & SEC XBRL Financials

$169.98 -0.25% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $170.31

Balchem Corporation (BCPC) earns a Roarable Rating of B- (Buy) with 71/100 RQD Confidence. High-quality cash engine (35.7% gross margin, 14% return on capital) with steady institutional support. The company’s underlying cash engine and institutional positioning keep the composite score in the Green Buy zone.

ROARABLE B- • BUY Cap $5.40B

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on BCPC Below — or Connect Your Own ChatGPT / Claude

🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is BCPC stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

▼

As of 2026-11-03, Balchem Corporation (NASDAQ: BCPC) is rated B- (Buy / BUY) by Roarable's 5-pillar RQD engine with a composite confidence score of 71/100 at a spot price of $169.98 (-0.25% 1D, market cap $5.40B). Pillar breakdown: Fundamental Cash Engine 16/20, Institutional 13F & Options Flow 11/20, SEC Balance-Sheet Forensics 18/20, FRED Macro Regime Fit 11/20, and Executive Insider Alignment 15/20. Across 270 tracked Materials issuers, BCPC ranks #8 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief

🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does BCPC compare to CE and MEOH in the Materials sector?

▼

Within the Materials sector (Major Chemicals), BCPC carries a Roarable B- (71/100 RQD), trailing P/E of 35.0x, gross margin of 35.7%, and ROIC of 14.0%. By comparison, CE (Celanese Corporation) holds a D grade (44/100 RQD, P/E N/A, ROIC -10.7%, cap $5.41B) and MEOH (Methanex Corporation) posts a C grade (65/100 RQD, P/E N/A, ROIC —, cap $5.54B). Among the 5-stock peer group, BCPC leads on earnings multiple (35.0x) while BCPC leads on capital efficiency (14.0% ROIC).

✓ Pre-computed one-to-many AI Quant brief

🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for BCPC?

▼

Per BCPC's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0000009326), Balchem Corporation generated $1.04B in revenue (+8.8% YoY), $154.8M in net income, and $216.6M in free cash flow against $1.69B in total assets and $0 in total debt. Key quantitative strengths: Strong cash generator (35.7% gross margin)—profits are backed by real money, not accounting tricks. Primary risk factors monitored: Broader market pullbacks can still drag down strong stocks in the short run. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief

🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $170.32 (+0.20%)🧬 Cannibal Buyback (-2.08% YoY Shares)⚙️ Cash Engine: 16/20 (B+) • 20.9% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record: Scores of 71/100 (B-) historically ranked in the Top 14% of excess returns over the next 90 days (+6.8% avg 90D alpha vs SPY • 68.4% hit rate).

Audit Bucket Track Record →

RQD QUANT TACHOMETERBUY • B-

2-of-3 JEV AI Jury Bullish

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw B- · Rk B

Each axis scored 0–20

12M PRICE TARGET CONE+5.8% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for BCPC)Realized 20D OHLCV Swing Band: ±4.5%

Deterministic 5-Pillar Attribution (71/100 Composite)

🔍 WHY BCPC SCORES 71/100 (B-) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: SEC 10-K Forensic Risk+18/20 pts (25% of score)

Altman Z-Score 9.67 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 8/9

▲ #2 Bullish Driver: Cash Engine Quality+16/20 pts (23% of score)

SEC XBRL FY 2025 (10-K): 20.9% FCF Margin ($216.6M FCF) & 35.7% Gross Margin

▼ #1 Drag / Risk Factor: Macro Regime Fit11/20 pts (-9 pt drag)

Macro rate sensitivity & RSI-14 (50.4) create a -9 pt regime headwind

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade C+$169.72+1.1% Next Q

Q2 (-2Q)

Grade B-$171.62-1.7% Next Q

Q3 (-1Q)

Grade B-$168.70+0.8% Next Q

Current

Grade B-$169.98+6.8% Hist 90D α

Trajectory: C+ (63) → B- (71)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)GIDEON ASHMERE // FORENSIC SHORT & KILL-SWITCH DOSSIER

⚔️ Adversarial Opposing Case: Why the BCPC Bull Thesis Could Fail

Gideon Ashmere Forensic Desk →

Even with a 71/100 (B-) score, BCPC faces multiple-compression risk if 35.0x trailing P/E re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.

⚠️ Forensic Kill-Switch #1

Broader market pullbacks can still drag down strong stocks in the short run.

⚠️ Forensic Kill-Switch #2

Dilution & Margin Drag: Cannibal Buyback (-2.08% YoY Shares) — any gross margin slip below 33.2% triggers an automatic RQD downgrade.

⚠️ Forensic Kill-Switch #3

Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($169.80) or 200D SMA ($169.29) invalidates the momentum regime and cuts Target Base ($179.92) toward Bear Floor ($139.38).

🎲 LIVE PREDICTION MARKET ODDS TIED TO $BCPC• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “BCPC Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”

YES 71%NO 29%Trade / Inspect Odds →

VISUAL REVENUE-TO-PROFIT SANKEY WATERFALL • FY 2025 (10-K)

How BCPC Turns Every Dollar of Sales Into Real Bottom-Line Profit

Free Cash Flow:$216.6M (20.9% FCF Margin)

Multi-Year SEC EDGAR XBRL Revenue, Net Profit & Free Cash Flow Trajectory

■ Revenue■ Net Profit■ Free Cash Flow

FY23

Rev $922.4M

FY24

Rev $953.7M

FY25

Rev $1.04B

Fiscal Year	Revenue	Gross Margin	Op Margin	Net Profit	Free Cash Flow	ROIC %
FY 2025	$1.04B	35.7%	20.2%	$154.8M	$216.6M	14%
FY 2024	$953.7M	35.3%	19.2%	$128.5M	$182.0M	13.1%
FY 2023	$922.4M	35.7%	17.3%	$108.5M	$183.8M	14%

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring BCPC)

✓Walkthrough of BCPC's RQD Radar, SEC cash-conversion gap & downside invalidation levels
✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

BCPC // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +4.86%📐 HORIZONTAL RANGE

2026-11-03O $170.4H $170.4L $170.0C $170.0VOL 249.3K

RES: $178.0SUP: $161.7SMA50: $169.8SMA200: $169.3

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

BCPC Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 BCPC Butterfly Map → + Track BCPC →

Share Count & Dilution Monitor

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle

27.0%/yr Implied 5Y Growth

vs. +8.8% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger

No active Ellis Vennor swing setup published on BCPC today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for BCPC. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for BCPC today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (BCPC)

Materials Rank #8 of 270 ⚔️ CE vs BCPC Full Matrix →

1. Head-to-Head Materials Peer Comparison (BCPC vs. CE, MEOH, SXT, HXL)

Industry: Major Chemicals (67 Tracked Issuers)

Across 270 tracked Materials securities in the Roarable RQD universe, Balchem Corporation (BCPC) ranks #8 by composite RQD confidence (71/100, grade B-) and #70 by equity capitalization ($5.40B). Within this direct 5-issuer industry benchmark cohort, BCPC leads on earnings valuation at 35.0x trailing P/E, while BCPC leads on capital efficiency and profitability with 14.0% ROIC and 35.7% gross margin. BCPC currently leads its immediate peer cohort in composite quantitative strength at 71/100 (B-).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
BCPC ACTIVE Balchem Corporation	B-	71/100	35.0x	35.7%	14.0%	-0.25%	$5.40B	Benchmark Subject
CE Celanese Corporation	D	44/100	—	20.5%	-10.7%	+2.03%	$5.41B	/ce-vs-bcpc →
MEOH Methanex Corporation	C	65/100	—	—	—	+14.04%	$5.54B	/meoh-vs-bcpc →
SXT Sensient Technologies Corporation	D+	55/100	41.6x	33.5%	8.8%	-10.57%	$5.01B	/sxt-vs-bcpc →
HXL Hexcel Corporation	D	51/100	55.0x	23.0%	6.2%	-2.15%	$5.89B	/hxl-vs-bcpc →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0000009326 ↗

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Balchem Corporation (BCPC) reported GAAP revenue of $1.04B (+8.8% vs. FY2024 revenue of $953.7M , and +12.4% cumulative change since FY2023) , GAAP net income of $154.8M, operating cash flow of $216.6M, and free cash flow of $216.6M (+19.0% YoY). On the balance sheet, BCPC closed FY2025 with $1.69B in total assets against $0 in total debt (Altman Z-Score: 9.67, Piotroski F-Score: 8/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$1.04B	$154.8M	$216.6M	$216.6M	$1.69B	—
FY2024 (FY)	2024-12-31	$953.7M	$128.5M	$182.0M	$182.0M	$1.58B	—
FY2023 (FY)	2023-12-31	$922.4M	$108.5M	$183.8M	$183.8M	—	—

3. BCPC Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is BCPC stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

How does BCPC compare to CE and MEOH in the Materials sector?

What are the biggest fundamental strengths and SEC risk factors for BCPC?

Where is BCPC trading relative to its 50-day, 200-day, and 52-week technical levels?

BCPC last traded at $169.98 (-0.25% on volume of 249,328 shares), positioning the stock +0.11% above its 50-day simple moving average ($169.80) and +0.41% above its 200-day simple moving average ($169.29). Across its 52-week range of $147.18 to $183.90, BCPC sits at the 62.1% percentile with a 14-day RSI of 50.4 (NEUTRAL RANGE) and an implied next-earnings move of ±4.5% ($162.33 to $177.63).

Direct Sub-Reports: BCPC RQD Cockpit BCPC 12M Forecast BCPC Earnings & Move BCPC Dividends & DRIP BCPC Insiders & 13F BCPC Whale Options BCPC Profit Sankey BCPC News & Why

ROARABLE RATING BRIEF • RQD 71/100 (B-) ✓ SEC XBRL & RQD VERIFIED

BCPC — Balchem Corporation: What the Facts Mean to a Prospective Investor

Methodology: RQD v6.2 Deterministic 5-Pillar & SEC XBRL Audit

Updated: 2025-12-31

1. Roarable Rating Brief: What This Means to a Prospective Investor

Balchem Corporation (BCPC) earns a live Roarable RQD composite score of 71/100, corresponding to a B- letter grade (Roarable Buy) at a spot price of $169.98 (-0.25% 1D, market capitalization $5.40B).

Fundamental Cash Engine (16/20): Anchored by return on invested capital (ROIC) of 14.0%, gross margin of 35.7%, operating margin of 20.2%, and free cash flow yield of 4.00%.
Whale 13F & Options Flow (11/20) + Insider Conviction (15/20): Tracks institutional 13F accumulation, CBOE options call/put positioning, and SEC Form 4 / Congressional PTR filings.
Macro Regime Fit (11/20) + Forensic Balance Sheet (18/20): Incorporates a 1.00x equity beta, Altman Z-Score of 9.67, Piotroski F-Score of 8/9, and Debt/Equity of N/A.

2. Business Model, Unit Margins & SEC Financial Trajectory

Balchem Corporation (BCPC) is a NASDAQ-listed issuer in the Materials sector, Major Chemicals industry. The company's products, customer base, and revenue model are — Reported gross margin is 35.7%, operating margin 20.2%, and net margin 14.9% per the market data section.

In its latest audited SEC EDGAR 10-K filing for FY2025 (filed 2025-12-31), Balchem Corporation (BCPC) reported $1.04B in annual revenue (up from $953.7M in FY2024, +8.8% YoY) and $154.8M in GAAP net income. Over the multi-year SEC filing window from FY2023 ($922.4M revenue, $108.5M net income) through FY2025, BCPC scaled operating cash flow to $216.6M and free cash flow to $216.6M, backed by $1.69B in total assets against $0 in total debt.

3. Institutional Bull vs. Bear Thesis & Valuation Tradeoff

🐂 Primary Bull Case (B- • RQD 71/100): Strong cash generator (35.7% gross margin)—profits are backed by real money, not accounting tricks. Company leadership has skin in the game with net positive insider conviction. With Fundamental Cash Engine at 16/20 and Institutional Whale Flow at 11/20, sustained execution supports upside toward the upper end of the $147.18 – $183.90 52-week range.
🐻 Primary Bear Case & Valuation Risk: Broader market pullbacks can still drag down strong stocks in the short run. Investors must weigh 35.0x trailing P/E and 25.5x EV/EBITDA against 20.2% operating margins and a 1.00x macro beta.

4. 2nd-Order Butterfly Ripples & Key Questions to Watch

Upstream and downstream dependencies: — Sector correlations: — Second-order bottlenecks: — Investors should watch for these relationships in future data, as the absence of mapped links means this section cannot evaluate ripple effects.

Key Question #1: Can BCPC sustain or expand its 20.2% operating margin and 14.0% ROIC against Major Chemicals peers over the next 4 quarters?
Key Question #2: Following FY2025 revenue of $1.04B and free cash flow of $216.6M, how will capital allocation balance growth reinvestment against $0 in total debt?
Key Question #3: How sensitive is BCPC's 32.6x forward P/E multiple to Materials capital spending cycles and macro interest-rate shifts (Beta 1.00x)?

BCPC Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for Balchem Corporation (BCPC) • Click "Debate This Headline" to argue it in the Roar Pit below

💬 Jump to BCPC Debate Forum (3) ↓

🟢 CATALYST Yahoo Finance • 1d ago

Update: Balchem Shares Rise After Q3 Beat

Yahoo Finance report covering Balchem Corporation (BCPC) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟢 CATALYST Seeking Alpha • 1d ago

Balchem: Record Sales, Great Fundamentals, Priced Fully, Hold (NASDAQ:BCPC)

Seeking Alpha report covering Balchem Corporation (BCPC) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE ChartMill • 1d ago

BCPC Stock Price, Quote & Chart

ChartMill report covering Balchem Corporation (BCPC) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE marketscreener.com • 1d ago

Earnings Flash (BCPC) Balchem Corporation Posts Q3 Adjusted EPS $1.57 per Share, vs. FactSet Est of $1.54

marketscreener.com report covering Balchem Corporation (BCPC) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟢 CATALYST Stock Titan • 1d ago

Quarterly sales and profit set records at Balchem. Sales reached $290.7 million.

Stock Titan report covering Balchem Corporation (BCPC) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Yahoo Finance • 1d ago

Balchem Corporation (BCPC) Stock Forecasts

Yahoo Finance report covering Balchem Corporation (BCPC) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Seeking Alpha • 1d ago

Balchem Corporation 2026 Q3 - Results - Earnings Call Presentation (NASDAQ:BCPC) 2026-10-26

Seeking Alpha report covering Balchem Corporation (BCPC) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🔴 RISK WATCH StocksToTrade • 1d ago

Balchem Falls 3% After Analyst Cuts Target

StocksToTrade report covering Balchem Corporation (BCPC) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE 3 Active Posts & Replies

BCPC Bull vs. Bear Conversation Board — What's Your Call at $169.98?

🐂 67% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON BCPC 🐻 33% BEARISH CONVICTION

DE DeltaGamma_99 RQD DEBATE OPENER • Options Flow Specialist 🐂 BULLISH 🎯 Target: $214.17 (+26.0%)

📌 Pinned Debate

Forensic balance sheet scores 18/20 with Altman Z 9.67 and Piotroski F 8/9, and FY 2025 net income rose to $154.8M on $1.04B revenue.

Long BCPC at $169.98 targeting $214.17. Forensic balance sheet scores 18/20 with Altman Z 9.67 and Piotroski F 8/9, and FY 2025 net income rose to $154.8M on $1.04B revenue.. Institutional whale score is 11/20 and the risk/reward vs. the $147.18 52-week low is skewed heavily in favor of bulls.

ArenaChamp_24 🐂 BULL

@BearTrap_Alert Fair point on 35.0x trailing P/E, but you're ignoring the forward operating leverage in Major Chemicals. If gross margin (35.7%) holds, EPS grows into the multiple faster than bears think.

BE BearTrap_Alert RQD DEBATE OPENER • Cycle Peak Watcher 🐻 BEARISH 🎯 Target: $146.18 (-14.0%)

Spot @ $169.98

A 35x trailing P/E and 4% FCF yield leave the stock priced for growth, with the whale-flow pillar scoring only 11/20.

Fading this rally in BCPC at $169.98. A 35x trailing P/E and 4% FCF yield leave the stock priced for growth, with the whale-flow pillar scoring only 11/20.. With a beta of 1.0 and the stock sitting at $169.98 (52-wk range $147.18–$183.90), the easy multiple expansion is already priced in.